Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Tertiary Amine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN103270015B reveals hydrogen recycling for tertiary amine synthesis, offering cost reduction and supply chain reliability for fine chemical intermediates.
Patent CN114853633B reveals a novel two-step nitrile ethylation process for high-purity alicyclic amines, offering significant cost reduction and supply chain reliability for epoxy curing agent manufacturing.
Patent CN109206319B reveals a solvent-free iridium catalytic route for tertiary amines, delivering high yields and sustainability for pharmaceutical intermediates.
Patent CN1124265C details a scalable aromatic bisimide process eliminating chromatography. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN1154689A reveals a safer, high-yield process for X-ray contrast agent intermediates using tertiary amines and specific hydrocarbon solvents.
Novel BCl3 catalyzed route improves yield and safety for SGLT2 inhibitor manufacturing supply chain reliability and cost efficiency significantly for global buyers.
Patent CN116924916B details a novel catalyst-free reductive amination method offering high selectivity and supply chain stability for pharmaceutical intermediates manufacturing.
Patent CN107778241B details a metal-free route for dihydrophenanthridines, offering cost-effective manufacturing and simplified supply chains for pharma intermediates.
Patent CN114292153A reveals a mild catalytic halogenation method using tertiary amines. This breakthrough offers cost reduction in pharmaceutical intermediate manufacturing with high selectivity.
Novel synthesis avoids toxic amines. High purity hole transport materials. Cost-effective scale-up for display industry.
Patent CN113061091B reveals a green Cu-Co/Al2O3 catalytic route for N-alkylation. Offers cost reduction and high purity for pharmaceutical intermediates manufacturing.
Patent CN107935882B reveals a mild Bronsted acid catalyzed route for high-purity azo compounds, offering significant cost reduction and supply chain reliability for global pharmaceutical manufacturers.
Advanced preparation method for 2-methylene glutaric acid using composite catalysts. Enhances yield and purity for polymer and agrochemical applications while reducing costs.
Patent CN108779105A reveals selective Buchwald-Hartwig arylation for high-purity OLED intermediates reducing purification costs significantly. This advanced method ensures reliable supply chain continuity and cost reduction in electronic chemical manufacturing for global partners.
Novel tertiary amine-thiourea catalyst enables high-yield asymmetric conjugate addition for scalable API intermediate production with superior enantioselectivity.
Patent CN111848322B details a novel organocatalytic resolution for axially chiral oxindole-substituted styrenes, offering high enantioselectivity and mild conditions for pharmaceutical intermediate manufacturing.
Discover advanced axial chiral styrene tertiary amine thiourea catalysts offering superior enantioselectivity and mild reaction conditions for pharmaceutical intermediate manufacturing.
Patent CN114907215B reveals mild decarbonylative hydroamination. Enables cost reduction in pharma manufacturing with high-purity amine intermediates and scalable processes.
Solve chiral synthesis challenges with this one-pot two-step method. Achieve 95% ee, 80-89% yield, and simplified production for pharmaceutical intermediates.